.jpg?format=webp&width=780)
This study investigates the impact of Medicare coverage on the diagnosis and treatment of head and neck squamous cell carcinoma (HNSCC) in individuals aged 60-70 in the US from 2000 to 2016. The study defines a "Medicare effect" as an increase in incidence, reduction in advanced stage presentation, and/or decrease in cancer-specific mortality. The results suggest that compared to Medicaid or uninsured patients, those aged 65 with Medicare have a decreased incidence of HNSCC, less late-stage diagnosis, lower cancer-specific mortality, and a higher likelihood of receiving cancer-specific surgery. Therefore, the study supports the idea of a "Medicare effect" in HNSCC.
Like
Save
Share